An internal standard for the quantification of oxprenolol
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Oxprenolol-d7

Item No. 33274

Technical Information
Formal Name
1-(2-(allyloxy)phenoxy)-3-((propan-2-yl-d7)amino)propan-2-ol
CAS Number
1189805-10-4
Synonyms
  • dl-Alprenolol-d7
  • dl-Oxprenolol-d7
Molecular Formula
C15H16D7NO3
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: solubleDMSO: solubleMethanol: soluble
SMILES
[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])NCC(O)COC1=C(C=CC=C1)OCC=C
InChi Code
InChI=1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3/i2D3,3D3,12D
InChi Key
CEMAWMOMDPGJMB-JLTHDCAWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Oxprenolol-d7 is intended for use as an internal standard for the quantification of oxprenolol (Item No. 16080) by GC- or LC-MS. Oxprenolol is an orally bioavailable β-adrenergic receptor (β-AR) antagonist (Ki = 7.10 nM in a radioligand binding assay using rat heart tissue).1 It is non-selective and binds to both β1- and β2-ARs (Kds = 2.09 and 1.35 nM in isolated rat heart and uterus, respectively).2 Oxprenolol is selective for β-ARs over serotonin (5-HT) receptors in rat sarcolemmal membrane preparations (IC50s = 4.13 and 23,300 nM, respectively), but it binds to 5-HT1A receptors in rat hippocampus and 5-HT1B in rat striatum (Kis = 94.2 and 642 nM, respectively).3,4 Formulations containing oxprenolol have been used to treat hypertension and angina pectoris.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nagatomo, T., Sasaki, M., Tsuchihashi, H., et alBinding characteristics of 3H-dihydroalprenolol to β-adrenoceptors of rat heart treated with neuraminidase. Jpn. J. Pharmacol. 33(4), 851-857 (1983).

    2. Abrahamsson, T. The β1- and β2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: A study in the isolated right atrium and uterus of the rat. Br. J. Pharmac. 87(4), 657-664 (1986).

    3. Moretti-Rojas, I., Ezrailson, E.G., Birnbaumer, L., et alSerotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity. The Journal of Biological Chemisty 258(20), 12499-12508 (1983).

    4. Langlois, M., Brémont, B., Rousselle, D., et alStructural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors. Eur. J. Pharmacol. 244(1), 77-87 (1993).

    5. Russo, M.E., and Covinsky, J.O. Oxprenolol hydrochloride: Pharmacology, pharmacokinetics, adverse effects and clinical efficacy. Pharmacotherapy 3(2), 68-81 (1983).